Bernstein Karen
SEC insider (Form 3/4/5 filer). CIK 0001654055. Director at Ovid Therapeutics Inc. (OVID). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in NEW YORK, NY.
Companies Bernstein Karen has filed insider reports for
- Ovid Therapeutics Inc. (OVID): Director
Bernstein Karen
CIK: 0001654055
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OVID
Ovid Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 26, 2026OVID
Ovid Therapeutics Inc.
AwardDirectEmployee Stock Option (Right to Buy)
65K shares- - Feb 20, 2025OVID
Ovid Therapeutics Inc.
AwardDirectStock Option (right to buy)
45K shares- - Dec 12, 2024OVID
Ovid Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
90K shares-
1-3 of 3 transactions